Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It Work
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Link
http://link.springer.com/content/pdf/10.1007/s11899-017-0374-1.pdf
Reference83 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.
2. Kumar SK, Lee JH, Lahuerta JJ, et al. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia. 2012;26(1):149–57.
3. •• Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised international staging system for multiple myeloma: a report from International Myeloma Working Group. J Clin Oncol. 2015;33(26):2863–9. This paper presents the most recent version of IMWG consensus criteria for risk stratification. These revised criteria now include the patients’ cytogenetic information; absence of which was a major limitation of the previous criteria.
4. • Sonneveld P, Avet-Loiseau H, Lonial S, et al. Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group. Blood. 2016;127(24):2955–62. Summarizes the IMWG recommendations for the treatment of cytogenetically high-risk myeloma.
5. Smith D, Yong K. Advances in understanding prognosis in myeloma. Br J Haematol. 2016;175(3):367–80.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed Refractory Multiple Myeloma;2024-01-24
2. Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice;CA: A Cancer Journal for Clinicians;2023-01-10
3. Hematopoietic Cell Transplantation;Holland‐Frei Cancer Medicine;2022-10-21
4. Boosting Immunity against Multiple Myeloma;Cancers;2021-03-11
5. Chimeric Antigen Receptor T-cell Therapy for Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3